Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium

R. W. Roudijk, K. Taha, M. Bourfiss, P. Loh, L. van den Heuvel, M. J. Boonstra, F. van Lint, S. M. van der Voorn, A. S. J. M. te Riele, L. P. Bosman, I. Christiaans, T. A. B. van Veen, C. A. Remme, M. P. van den Berg, J. P. van Tintelen, F. W. Asselbergs*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

24 Downloads (Pure)


In relatives of index patients with dilated cardiomyopathy and arrhythmogenic cardiomyopathy, early detection of disease onset is essential to prevent sudden cardiac death and facilitate early treatment of heart failure. However, the optimal screening interval and combination of diagnostic techniques are unknown. The clinical course of disease in index patients and their relatives is variable due to incomplete and age-dependent penetrance. Several biomarkers, electrocardiographic and imaging (echocardiographic deformation imaging and cardiac magnetic resonance imaging) techniques are promising non-invasive methods for detection of subclinical cardiomyopathy. However, these techniques need optimisation and integration into clinical practice. Furthermore, determining the optimal interval and intensity of cascade screening may require a personalised approach. To address this, the CVON-eDETECT (early detection of disease in cardiomyopathy mutation carriers) consortium aims to integrate electronic health record data from long-term follow-up, diagnostic data sets, tissue and plasma samples in a multidisciplinary biobank environment to provide personalised risk stratification for heart failure and sudden cardiac death. Adequate risk stratification may lead to personalised screening, treatment and optimal timing of implantable cardioverter defibrillator implantation. In this article, we describe non-invasive diagnostic techniques used for detection of subclinical disease in relatives of index patients with dilated cardiomyopathy and arrhythmogenic cardiomyopathy.

Original languageEnglish
Number of pages6
JournalNetherlands Heart Hournal
Early online date2-Feb-2021
Publication statusPublished - 2-Feb-2021


  • Pathogenic variants
  • Cascade screening
  • Arrhythmogenic cardiomyopathy
  • Dilated cardiomyopathy
  • Plakophilin&#8209
  • 2
  • Phospholamban

Cite this